Investing Profile

Jim Trenkle

InvestorVC
Head of Investments at Sanofi Ventures
sanofiventures.com/team/index...Cambridge, Massachusetts
Photo of Jim Trenkle, Investor at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$5.0M - $10.0M
$7.5M
5
CompanyStageDateRound SizeTotal Raised
Convergent Therapeutics
Series ASep 2024$40M
$130M
Co-investors: Jake Simson (RA Capital)
MapLight Therapeutics
Series COct 2023$230M
$230M
ROME Therapeutics
Series BSep 2021$77M
$130M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Kristina Burow (ARCH Venture Partners), Steve Kafka (Section 32)
Glycomine
Series BJun 2021$35M
$150M
Co-investors: Niall O’Donnell (RiverVest), Dominic Schmidt (Advent Life Sciences), Bali Muralidhar (Abingworth)
Therini Bio
SeedMay 2021$17M
$100M
Co-investors: Laurence Barker (SV Health Investors), Houman Ashrafian (SV Health Investors), Mike Ross (SV Health Investors), Pascal Levensohn (Dolby Family Ventures)